The Daily

Marriage and Sex in the Age of Ozempic: An Update

Dec 26, 2025 · 24 min · 23.8 MB
0:00-24:47

Streams straight from the publisher. podnod never proxies or re-hosts episode audio.

This week, The Daily is revisiting some of our favorite episodes of the year and checking in on what has happened in the time since.

In the past few years, GLP-1 weight-loss drugs like Ozempic and Zepbound have been radically reshaping the people’s lives, changing appetites and health.

But the drugs also have the power to affect other parts of consumers’ lives, including their romantic relationships.

Lisa Miller, who writes about health for The New York Times, tells the story of how these drugs upended one couple’s marriage.

Guest: Lisa Miller, a domestic correspondent for the Well section who writes about personal and cultural approaches to physical and mental health.

Background reading: 

Photo: Katherine Wolkoff for The New York Times

For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday. 

Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Thank you for listening to this episode of Daily News. We've gathered all the additional resources, book For more updates and exclusive content, visit our official site: ➡️ 🚨[VIP ACCESS]🚨

Subscribe and leave a review! ➡️ SUBSCRIBE


Copyright Disclaimer: We are not the official Daily news or Spotify feed. All rights to the original content belong to their respective owners. This channel is sustained through dynamic ad insertion to offset AI processing, hosting, and transcription costs.


Hosted on Acast. See acast.com/privacy for more information.